Activation of P-1 purinergic receptors by adenosine and P-2 receptors by AT
P plays an important role in pulmonary vasodilation that occurs at birth in
fetal lambs. Purine receptors occur in several subtypes, and the effects o
f their stimulation vary with the specific type involved. We characterized
the subtypes of P-1 receptors in fetal lamb pulmonary circulation at 128-13
2 d gestation by investigating the effects of the following adenosine analo
gs: N-6-cyclopentyl adenosine (A(1) selective), 2-phenylaminoadenosine (A(2
) selective), 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadeno
sine (A(2A) selective), N-6-benzyl-5'-N-ethylcarboxamidoadenosine (A(3) sel
ective), and adenosine and 5'-N-ethylcarboxamidoadenosine (nonselective). W
e repeated the studies after treatment of animals with A(1) antagonist 1,3-
dipropyl-8-cyclopentylxanthine. or A(2) antagonist 1,3-dipropyl-7-methylxan
thine. Identification of P-2 receptors was done by investigation of the eff
ects of P-2x agonist beta,gamma-methylene-L-ATP and P-2x and P-2y agonist A
TP. The studies were repeated after the treatment of animals with P-2x anta
gonist suramin and the P-2y antagonist cibacron blue. N-6-cyclopentyl adeno
sine caused a significant decrease in heart rate and did not change pulmona
ry blood flow or pulmonary vascular resistance (PVR). The effect of N-6-cyc
lopentyl adenosine on heart rate was abolished by 1,3-dipropyl-8-cyclopenty
lxanthine but not by 1,3-dipropyl-7-methylxanthine. 2-Phenylaminoadenosine,
2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine, 5'-N-et
hylcarboxamidoadenosine, and adenosine caused significant increases in pulm
onary how and decreases in PVR, and their vasodilator effects were attenuat
ed by the A(2) antagonist 1,3-dipropyl-7-methylxanthine and not by 1,3-dipr
opyl-8-cyclopentylxantbine. N-6-benzyl-5'-N-ethylcarboxamidoadenosine did n
ot alter pulmonary flow or PVR. The P-2x agonist beta,gamma-methylene-L-ATP
caused a decrease in heart rate and bad no effect on pulmonary how and PVR
. ATP caused a significant increase in pulmonary flow and decrease in PVR w
ithout affecting heart rate. The vasodilator effects of ATP were attenuated
by cibacron blue and not by suramin. These data demonstrate that adenosine
and ATP cause pulmonary vasodilation by activation of A(2A) and P-2y recep
tors, respectively, in fetal lambs.